{
    "relation": [
        [
            "Feature key",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei"
        ],
        [
            "Position(s)",
            "1 \u2013 243",
            "1 \u2013 159",
            "1 \u2013 138",
            "75 \u2013 100",
            "102 \u2013 199",
            "160 \u2013 293",
            "200 \u2013 331",
            "294 \u2013 331",
            "310 \u2013 320",
            "321 \u2013 331"
        ],
        [
            "Length",
            "243",
            "159",
            "138",
            "26",
            "98",
            "134",
            "132",
            "38",
            "11",
            "11"
        ],
        [
            "Description",
            "Missing in isoform 6. 1 Publication Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.8 \"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).\" The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 6).",
            "MRFRF\u2026MHYSR \u2192 MIFNK in isoform 7. 1 Publication Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.5 \"Complete sequencing and characterization of 21,243 full-length human cDNAs.\" Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S. Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 7 AND 8).",
            "Missing in isoform 8. 2 Publications Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.4 \"Cloning of differentially spliced transcripts of the EPM2A gene.\" Ganesh S., Yamakawa K. Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 8), NUCLEOTIDE SEQUENCE [MRNA] OF 25-331 (ISOFORM 4), NUCLEOTIDE SEQUENCE [MRNA] OF 75-331 (ISOFORM 3). Ref.5 \"Complete sequencing and characterization of 21,243 full-length human cDNAs.\" Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S. Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 7 AND 8).",
            "GAEPG\u2026ELSWE \u2192 LVKIGSAPETRSKIFPRFTI RRRLSR in isoform 3. 1 Publication Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.4 \"Cloning of differentially spliced transcripts of the EPM2A gene.\" Ganesh S., Yamakawa K. Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 8), NUCLEOTIDE SEQUENCE [MRNA] OF 25-331 (ISOFORM 4), NUCLEOTIDE SEQUENCE [MRNA] OF 75-331 (ISOFORM 3).",
            "NGPHH\u2026EWDIV \u2192 IASRRLPPAQSGSSGPHPQP GPRPRAGPAGPGGARPGLFA RVPAHSPGDLG in isoform 4. 1 Publication Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.4 \"Cloning of differentially spliced transcripts of the EPM2A gene.\" Ganesh S., Yamakawa K. Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 8), NUCLEOTIDE SEQUENCE [MRNA] OF 25-331 (ISOFORM 4), NUCLEOTIDE SEQUENCE [MRNA] OF 75-331 (ISOFORM 3).",
            "Missing in isoform 5. Curated",
            "Missing in isoform 4. 1 Publication Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.4 \"Cloning of differentially spliced transcripts of the EPM2A gene.\" Ganesh S., Yamakawa K. Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 8), NUCLEOTIDE SEQUENCE [MRNA] OF 25-331 (ISOFORM 4), NUCLEOTIDE SEQUENCE [MRNA] OF 75-331 (ISOFORM 3).",
            "YFLMA\u2026SVCSL \u2192 PSTDAAPGGVPAACAAGEGT HRVRALQRWGGPLHRGCLRL APVCDGLESEEGAVFPHGQE AGCLH in isoform 5. Curated",
            "LARAQEDFFQK \u2192 ASQDTFPL in isoform 2. 2 Publications Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.1 \"Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy.\" Minassian B.A., Lee J.R., Herbrick J.-A., Huizenga J., Soder S., Mungall A.J., Dunham I., Gardner R., Fong C.G., Carpenter S., Jardim L., Satishchandra P., Andermann E., Snead O.C. III, Lopes-Cendes I., Tsui L.-C., Delgado-Escueta A.V., Rouleau G.A., Scherer S.W. Nat. Genet. 20:171-174(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), ALTERNATIVE SPLICING, PROBABLE FUNCTION, TISSUE SPECIFICITY, VARIANTS EPM2 CYS-108; SER-279 AND LEU-293, VARIANT ASP-114. Ref.9 \"A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2).\" Serratosa J.M., Gomez-Garre P., Gallardo M.E., Anta B., de Bernabe D.B., Lindhout D., Augustijn P.B., Tassinari C.A., Malafosse R.M., Topcu M., Grid D., Dravet C., Berkovic S.F., de Cordoba S.R. Hum. Mol. Genet. 8:345-352(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 82-331 (ISOFORMS 1 AND 2), VARIANTS EPM2 HIS-171; ILE-194; SER-279 AND ASN-294.",
            "Missing in isoform 2. 2 Publications Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.1 \"Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy.\" Minassian B.A., Lee J.R., Herbrick J.-A., Huizenga J., Soder S., Mungall A.J., Dunham I., Gardner R., Fong C.G., Carpenter S., Jardim L., Satishchandra P., Andermann E., Snead O.C. III, Lopes-Cendes I., Tsui L.-C., Delgado-Escueta A.V., Rouleau G.A., Scherer S.W. Nat. Genet. 20:171-174(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), ALTERNATIVE SPLICING, PROBABLE FUNCTION, TISSUE SPECIFICITY, VARIANTS EPM2 CYS-108; SER-279 AND LEU-293, VARIANT ASP-114. Ref.9 \"A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2).\" Serratosa J.M., Gomez-Garre P., Gallardo M.E., Anta B., de Bernabe D.B., Lindhout D., Augustijn P.B., Tassinari C.A., Malafosse R.M., Topcu M., Grid D., Dravet C., Berkovic S.F., de Cordoba S.R. Hum. Mol. Genet. 8:345-352(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 82-331 (ISOFORMS 1 AND 2), VARIANTS EPM2 HIS-171; ILE-194; SER-279 AND ASN-294."
        ],
        [
            "Graphical view",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ],
        [
            "Feature identifier",
            "VSP_042494",
            "VSP_042495",
            "VSP_042493",
            "VSP_011014",
            "VSP_011015",
            "VSP_042496",
            "VSP_011016",
            "VSP_042497",
            "VSP_011017",
            "VSP_011018"
        ],
        [
            "Actions",
            "Add BLAST",
            "Add BLAST",
            "Add BLAST",
            "Add BLAST",
            "Add BLAST",
            "Add BLAST",
            "Add BLAST",
            "Add BLAST",
            "Add BLAST",
            "Add BLAST"
        ]
    ],
    "pageTitle": "EPM2A - Laforin - Homo sapiens (Human)",
    "title": "",
    "url": "http://www.uniprot.org/uniprot/O95278",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438044160065.87/warc/CC-MAIN-20150728004240-00260-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 801550287,
    "recordOffset": 801462177,
    "tableOrientation": "HORIZONTAL",
    "lastModified": "Wed, 22 Jul 2015 00:00:00 GMT",
    "textBeforeTable": "Alternative sequence VAR_046386 VARIANTS EPM2 ASN-140; TYR-148; LYS-210 AND TRP-310, CHARACTERIZATION OF VARIANT EPM2 TRP-310. Cited for: Abstract] Europe PMC] [ PubMed] [ Hum. Mutat. 29:E1-12(2008) [ Ganesh S. Shankar S.K., Satishchandra P., Singh S., \"Lafora disease in the Indian population: EPM2A and NHLRC1 gene mutations and their impact on subcellular localization of laforin and malin.\" Ref.36 <p>Manually curated information for which there is published experimental evidence.</p> <p><a href=\"/manual/evidences#ECO:0000269\">More\u2026</a></p> Manual assertion based on experiment ini L \u2192 W in EPM2; alters the subcellular localization of isoform 1; does not affect homodimerization of isoform 1 but prevents heterodimerization of isoform 1 and isoform 2. 1 Publication 1 310\u00a0\u2013\u00a0310 <p>Describes natural variant(s) of the protein sequence.</p><p><a href='../manual/variant' target='_top'>More...</a></p>Natural varianti VAR_019481",
    "textAfterTable": "Sequence databases Select the link destinations: EMBL nucleotide sequence database<br/><a href='/database/22'>More..</a>EMBLi GenBank nucleotide sequence database<br/><a href='/database/28'>More..</a>GenBanki DNA Data Bank of Japan; a nucleotide sequence database<br/><a href='/database/14'>More..</a>DDBJi Links Updated AF084535 mRNA. Translation: AAC83347.2. AF284580 mRNA. Translation: AAG18377.1. AF454491 mRNA. Translation: AAO15523.1. AF454492 mRNA. Translation: AAO15524.1. AF454493 mRNA. Translation: AAO15525.1. AF454494 mRNA. Translation: AAO15526.1. AK022721 mRNA. Translation: BAG51107.1. Frameshift. AK299497 mRNA. Translation: BAG61454.1. AL023806, AL365193 Genomic DNA. Translation: CAI21419.1. AL365193, AL023806 Genomic DNA. Translation: CAI21675.1. CH471051 Genomic DNA. Translation:",
    "hasKeyColumn": false,
    "keyColumnIndex": -1,
    "headerRowIndex": 0
}